AlphaYouADIL: Young Wendy B. discloses securities transactions
By AlphaYouPublished Form 4
Young Wendy B.
Reporting filer
Young Wendy B. reported Grant or award in ADIAL PHARMACEUTICALS, INC.: 25666 units of Stock Option (Right to Buy) (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 21, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Young Wendy B. | 2026-09-17 | A | Grant or award | 25666 | 0 | 25,666 | 4 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Young Wendy B.
- Date
- 2026-09-17
- Code
- A
- Action
- Grant or award
- Quantity
- 25666
- Price
- 0
- Following holdings
- 25,666
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 2.98
- transaction Date: 2026-09-17
- id: F1
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 25666
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- id: F2
- expiration Date: 2036-06-12
- underlying Security Title: Common Stock
- underlying Security Shares: 25666
- shares Owned Following Transaction: 25666
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Young Wendy B.: Director.
- F1: On June 11, 2026, the Issuer's board of directors approved the option grant issued to the Reporting Person on June 12, 2026, which grant was subject to stockholder approval of an amendment to the Issuer's 2017 Equity Incentive Plan to increase the number of shares authorized for issuance thereunder. The Issuer's stockholders approved the plan amendment on September 17, 2026 ("Stockholder Approval Date").
- F2: 2,138 shares subject to the stock option vested on the Stockholder Approval Date and the remaining 23,528 shares subject to the stock option shall vest in substantially equal installments over a 33-month period, beginning on October 12, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.